SWOG clinical trial number
SWOG-8832
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer
Closed
Phase
Accrual
6%
Abbreviated Title
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer
Activated
04/01/1989
Closed
11/15/1990